Status of Newborn Screening for Spinal Muscular Atrophy
National Program Active
SMA approved for NBS panel, pending implementation
Application for national program submitted
This is an interactive map, click on a country to learn more about the status of SMA NBS there.
- As of 1 October 2021, both Germany and Norway screen all newborns in that country for SMA.
- As of Spring 2021, Spinal Muscular Atrophy (SMA) is approved as part of the national newborn screening programme and awaiting implementation in the Netherlands, Ukraine, Serbia, Poland, and Slovenia.
- As of April 2021, there are newborn screening pilots for SMA ongoing in Italy and Spain with further pilots planned in the United Kingdom and France. Germany and Belgium concluded their pilot studies and SMA newborn screening continues in parts of those countries.
A pilot is a small, normally regional, study to test newborn screening research protocols, data collection instruments, sample strategies, and other research techniques in preparation for a larger study, or implementation of newborn screening for SMA nationwide.